Clinical Trial

Study of the Effectiveness of Dydrogesterone in the Treatment of Endometriosis-related Pain

Study acronym: Daisy
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 30, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The study is an observational, multicenter, prospective, single arm study to evaluate the efficacy of dydrogesterone in endometriosis-related pain (EAP).
Trial Details
NCT Number NCT06952296
Lead Sponsor Abbott
Conditions Endometriosis
Enrollment 250 participants
Start Date 2025-04
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-04-30